Cognitive and neurological research
Cerebrolysin
Also known as FPF-1070
A peptide preparation derived from porcine brain protein, studied for neurotrophic and neuroprotective signalling.
What it is
Cerebrolysin is not a single synthesised peptide but a mixture of low-molecular-weight peptides and amino acids produced by enzymatic breakdown of purified porcine brain protein. Its composition is defined by that process rather than by a sequence, which makes it unusual among research peptides and complicates direct comparison between batches and studies.
What published research examines
- Neurotrophic factor-like activity in neuronal culture
- Neuronal survival signalling under stress conditions
- Cognitive endpoints in clinical research populations
- Recovery research following ischaemic events
Where the research stands
Cerebrolysin has a comparatively large clinical literature, much of it from central and eastern Europe and Asia. Reviews have noted variation between trials and point to larger independent studies as the next step.